Skip to main content

Table 1 Demographics and clinical features of pediatric cases surgically treated for PIP. The numbers of age and time are averages with respective standard deviations

From: Epidemiology and treatment outcomes in pediatric patients with post-injection paralysis

Variable

Number

% of total patients with reported data (n=402)

Total number of patients

402

100

Sex

 Male

228

56.72

 Female

173

43.03

Unspecified

1

0.25

Patients with known date of injection (%)

188

46.77

Avg age when received inciting injection (yrs)

3.49 ± 2.87

 

 # of pts 0 – 4 yrs

137

34.08

 # of pts 5 – 9 yrs

40

10.00

 # of pts 10 – 17 yrs

11

2.74

Avg age at initial presentation to CoRSU hospital (yrs)

9.12 ± 3.94

 

 # of pts 0 – 4 yrs

55

13.68

 # of pts 5 – 9 yrs

169

42.04

 # of pts 10 – 14 yrs

132

32.84

 # of pts 15 – 17 yrs

46

11.44

Time from date of injection to initial presentation (yrs)

5.37 ± 3.50

 

Distance from home district to CoRSU (km)

154.66 ± 159.78

 

 # of pts 0 – 40 km

137

34.08

 # of pts 41 – 100 km

66

16.41

 # of pts 101 – 250 km

98

24.38

 # of pts 251+ km

94

23.34

Reported indications for injection

60

14.93

 Unspecified febrile illness

37

9.20

 Malaria

14

3.48

 Immunization

4

1.00

 Other

5

1.24

Affected PIP-side

 Right

234

58.21

 Left

166

41.29

 Bilateral

2

0.50

 Patients with pre-treatment

30

7.46

 skin complications Skin callus

11

2.74

 Superficial wound

3

0.75

 Ulcer

16

3.98

Foot deformity characterization

 Equinus

99

24.63

 Equinovarus

188

46.77

 Varus

22

5.47

 Cavovarus

23

5.72

 Calcaneus

3

0.75

 Unknown

67

16.67